Financing Drug Innovation: Cost versus Cure

被引：0
|
作者：
Antos, Joseph R. [1 ]
机构：
[1] Amer Enterprise Inst Publ Policy Res, Hlth Care & Retirement Policy, Washington, DC 20036 USA
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2015年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [1] Breaking the Bank: Three Financing Models for Addressing the Drug Innovation Cost Crisis
    Kleinke, J. D.
    McGee, Nancy
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (03): : 118 - 125
  • [2] Innovation in technology versus innovation in financing: two case studies
    Lethbridge, D
    [J]. TECHNOVATION, 2003, 23 (11) : 869 - 878
  • [3] Syndication and financing of innovation risk sharing versus expertise
    Legrand, Muriel Dal Pont
    Pommet, Sophie
    [J]. REVUE D ECONOMIE POLITIQUE, 2010, 120 (04): : 643 - 668
  • [4] Corporate social responsibility, debt financing cost and enterprise innovation
    Jing-jing Yao
    Yi-ang Qi
    Bing Guo
    [J]. Scientific Reports, 12
  • [5] Corporate social responsibility, debt financing cost and enterprise innovation
    Yao, Jing-jing
    Qi, Yi-ang
    Guo, Bing
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Financing Drug Innovation in the US: Current Framework and Emerging Challenges
    David Cutler
    Noam Kirson
    Genia Long
    [J]. PharmacoEconomics, 2020, 38 : 905 - 911
  • [7] Financing Drug Innovation in the US: Current Framework and Emerging Challenges
    Cutler, David
    Kirson, Noam
    Long, Genia
    [J]. PHARMACOECONOMICS, 2020, 38 (09) : 905 - 911
  • [8] Financing Innovation
    Kerr, William R.
    Nanda, Ramana
    [J]. ANNUAL REVIEW OF FINANCIAL ECONOMICS, VOL 7, 2015, 7 : 445 - 462
  • [9] FINANCING INNOVATION
    FOLKMAN, PJ
    [J]. ENGINEERING, 1974, 214 (11): : 917 - 919
  • [10] FINANCING INNOVATION
    GOURSAT, M
    [J]. DIRECTION ET GESTION, 1975, 11 (06): : 19 - 23
12345